Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women.

Abstract:

BACKGROUND:Although >70% of younger women with nonmetastatic breast cancer (BC) received adjuvant chemotherapy, only approximately 15% to 20% of elderly women with BC received chemotherapy. The decision to treat may be associated with nonmedical factors, such as patient, physician, or practice characteristics. In the current study, the association between oncologist characteristics and the receipt of chemotherapy in elderly women with BC was evaluated. METHODS:Women aged >65 years who were diagnosed with American Joint Committee on Cancer stages I to III BC between 1991 and 2002 were identified in the Surveillance, Epidemiology, and End Results-Medicare database. The Physician Unique Identification Number was linked to the American Medical Association Masterfile to obtain information on oncologists. Investigated was the association between demographic, tumor, and oncologist-related factors and the receipt of chemotherapy, using Generalized Estimating Equations to control for clustering. Patients were defined as low risk (estrogen/progesterone receptor positive, stage I/II disease) and high risk (estrogen/progesterone receptor-negative, stage II/III disease). RESULTS:Of 42,544 women identified, 8714 (20%) were treated with adjuvant chemotherapy. In a hierarchical analysis, women who underwent chemotherapy were more likely be treated by oncologists primarily employed in a private practice (odds ratio [OR], 1.40; 95% confidence interval [95% CI], 1.23-1.59) and who graduated after 1975 (OR, 1.12; 95% CI, 1.01-1.26) and were less likely to have an oncologist trained in the United States (OR, 0.83; 95% CI, 0.74-0.93). The association between a private practice setting and the receipt of chemotherapy was found to be similar for patients at high risk (OR, 1.55) and low risk (OR, 1.35) for cancer recurrence. CONCLUSIONS:Elderly women with BC treated by oncologists who were employed in a private practice were more likely to receive chemotherapy. Efforts to determine whether these associations reflected experience, practice setting, insurance type, or other economic incentives are warranted.

journal_name

Cancer

journal_title

Cancer

authors

Hershman DL,Buono D,McBride RB,Tsai WY,Neugut AI

doi

10.1002/cncr.24448

subject

Has Abstract

pub_date

2009-09-01 00:00:00

pages

3848-57

issue

17

eissn

0008-543X

issn

1097-0142

journal_volume

115

pub_type

杂志文章

相关文献

CANCER文献大全
  • Ocular toxicity and cancer chemotherapy. A review.

    abstract:BACKGROUND:Systemic anticancer therapies can produce acute and chronic organ damage, but the eye is usually considered a protected site. Nonetheless, the oculo-visual system has a potentially high degree of sensitivity to toxic substances. Ocular toxicity induced by cancer chemotherapy includes a broad spectrum of diso...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(SICI)1097-0142(19961001)78:7<1359::AID-CN

    authors: al-Tweigeri T,Nabholtz JM,Mackey JR

    更新日期:1996-10-01 00:00:00

  • AANCART best practices: cancer awareness activities for Seattle's Combodian community.

    abstract::Census data indicate that Cambodian Americans are economically disadvantaged and linguistically isolated. In addition, cancer registry data show that Southeast Asians experience several cancer-related health disparities (e.g., markedly elevated risks of cervical and liver cancer). The Seattle regional Asian American N...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21515

    authors: Seng P,Acorda E,Carey Jackson J,Marchand A,Thai H,Tu SP,Taylor V

    更新日期:2005-12-15 00:00:00

  • Prolymphocytic leukemia: treatment with combination chemotherapy to include doxorubicin.

    abstract::Prolymphocytic leukemia (PL) is a clinically distinct leukemic disorder. Cytochemical and surface marker characteristics help to differentiate PL from other types of leukemia, including chronic lymphocytic leukemia (CLL). In contrast to patients with CLL, those with PL frequently require early therapeutic intervention...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820415)49:8<1524::aid-cncr2820

    authors: Taylor HG,Butler WM,Rhoads J,Karcher DS,Detrick-Hooks B

    更新日期:1982-04-15 00:00:00

  • Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states.

    abstract::Elevated circulating CEA levels occur in patients with benign gastrointestinal and hepatic disorders. These are usually less than 10 ng/ml. Of clinical importance is the influence of liver disease on the interpretation of CEA. At least 50% of patients with severe benign hepatic disease have elevated CEA levels, most o...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(197809)42:3+<1412::aid-cncr28204

    authors: Loewenstein MS,Zamcheck N

    更新日期:1978-09-01 00:00:00

  • Perspectives on research in gynecologic oncology.

    abstract::Gynecologic cancers present unusual opportunities to explore the fruits of well-designed clinical trials to assess the value of existing treatment using a combined modality approach soon after diagnosis. Cancers of the ovary and uterus have well-defined, familiar natural histories. Pathways of spread are clear and rea...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,评审

    doi:10.1002/1097-0142(197607)38:1<509::aid-cncr2820380

    authors: DeVita VT Jr,Wasserman TH,Young RC,Carter SK

    更新日期:1976-07-01 00:00:00

  • Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials.

    abstract:BACKGROUND:Attrition is common among supportive care/palliative oncology clinical trials. However, to the authors' knowledge, few studies to date have documented the reasons and predictors for dropout. In the current study, the authors' objective was to determine the rate, reasons, and factors associated with attrition...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27854

    authors: Hui D,Glitza I,Chisholm G,Yennu S,Bruera E

    更新日期:2013-03-01 00:00:00

  • The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.

    abstract::A prospective study of four cycles of etoposide with ifosfamide and cisplatin (VIP) chemotherapy was conducted in 42 germ cell tumor (GCT) patients who were refractory to cisplatin with etoposide/vinblastine-based therapy. Forty patients were evaluable for response. Ten patients (25%) had a complete response: seven to...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19901215)66:12<2476::aid-cncr282

    authors: Motzer RJ,Cooper K,Geller NL,Bajorin DF,Dmitrovsky E,Herr H,Morse M,Fair W,Sogani P,Russo P

    更新日期:1990-12-15 00:00:00

  • A reliable method for evaluating drug compliance in children with cancer.

    abstract::Poor drug compliance may cause a decreased survival of children with malignancies. Children who fail to take their medications are not receiving optimum amounts of chemotherapy and suboptimal therapy causes a shortened survival in children with cancer. This is a study of prednisone compliance in 52 children with cance...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197901)43:1<169::aid-cncr2820430

    authors: Smith SD,Rosen D,Trueworthy RC,Lowman JT

    更新日期:1979-01-01 00:00:00

  • Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.

    abstract:BACKGROUND:Through this study, the authors sought to investigate the biologic and immunologic effects of preoperative trastuzumab in patients with ductal carcinoma in situ (DCIS) of the breast. METHODS:Patients with DCIS were enrolled in this open-label phase 2 trial and tested for HER2. Trastuzumab was given by intra...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25399

    authors: Kuerer HM,Buzdar AU,Mittendorf EA,Esteva FJ,Lucci A,Vence LM,Radvanyi L,Meric-Bernstam F,Hunt KK,Symmans WF

    更新日期:2011-01-01 00:00:00

  • Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site.

    abstract:BACKGROUND:Because carcinomas of unknown primary origin are highly malignant tumors with a bad prognosis (median survival, 6-12 months) and no current optimal therapy, the authors designed a prospective dose-dense chemotherapy regimen with the objective of improving the results observed in patients who receive conventi...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.10264

    authors: Culine S,Fabbro M,Ychou M,Romieu G,Cupissol D,Pinguet F

    更新日期:2002-02-01 00:00:00

  • Angioimmunoblastic lymphadenopathy progressing to immunoblastic lymphoma with prominent gastric involvement.

    abstract::Two unusual cases of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD), with progression to immunoblastic lymphoma (IL) and prominent gastric involvement are presented, and detailed immunohistologic studies described. In one case, Bence Jones proteinuria of the kappa type was observed during the course of ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19821115)50:10<2089::aid-cncr282

    authors: Bauer TW,Mendelsohn G,Humphrey RL,Mann RB

    更新日期:1982-11-15 00:00:00

  • The future of research that promotes cancer screening.

    abstract::The authors draw on the lessons highlighted in preceding articles in the current supplement to provide recommendations for cancer screening intervention research and to highlight some of the many questions that will require further investigation. ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.20510

    authors: Meissner HI,Vernon SW,Rimer BK,Wilson KM,Rakowski W,Briss PA,Smith RA

    更新日期:2004-09-01 00:00:00

  • Nerve sheath myxoma of digital nerve.

    abstract::A case of a dermal nerve sheath myxoma arising in a digital nerve is reported. Similar tumors and its variants have been termed neurothekeoma, pacinian neurofibroma, bizarre cutaneous neurofibroma, and plexiform neurofibroma. The perineural sheath or the Schwann cell have been presumed to be the cell of origin by seve...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19890315)63:6<1215::aid-cncr2820

    authors: Blumberg AK,Kay S,Adelaar RS

    更新日期:1989-03-15 00:00:00

  • Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?

    abstract:BACKGROUND:The results and consequences of genetic testing in a family with familial medullary thyroid carcinoma (FMTC) are described. METHODS:In the screening of relatives, serum calcitonin is replaced by RET mutation analysis that was performed in families suspected of hereditary medullary thyroid carcinoma (MTC). I...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Hansen HS,Torring H,Godballe C,Jäger AC,Nielsen FC

    更新日期:2000-08-15 00:00:00

  • Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience.

    abstract:BACKGROUND:Stereotactic radiation therapy is highly effective in the treatment of small brain metastases, regardless of the histology. This suggests that small extracranial malignancies may be curable with similar radiation therapy. The authors developed a novel treatment unit for administering such therapy. METHODS:T...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19980315)82:6<1062::aid-cn

    authors: Uematsu M,Shioda A,Tahara K,Fukui T,Yamamoto F,Tsumatori G,Ozeki Y,Aoki T,Watanabe M,Kusano S

    更新日期:1998-03-15 00:00:00

  • Malignant rhabdoid tumor of the pelvis.

    abstract::An extrarenal malignant rhabdoid tumor (MRT) of the pelvis in a 14-year-old girl is described. The location of the tumor and age of the patient appear to be unique. The neoplasm is histologically and ultrastructurally identical to malignant rhabdoid tumor of the kidney seen in infants and very young children. The tumo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850501)55:9<1963::aid-cncr2820

    authors: Frierson HF Jr,Mills SE,Innes DJ Jr

    更新日期:1985-05-01 00:00:00

  • Growth mode and DNA ploidy in mucosal carcinomas of the stomach.

    abstract::Modes of cancer growth and DNA ploidy were studied in 66 patients with mucosal carcinoma of the stomach. The modes of growth were classified into five histologic patterns; elongated tubular (three patients), expansive (18 patients), tubular and solid (14 patients), carcinoma in situ (10 patients) and infiltrative (21 ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870315)59:6<1154::aid-cncr2820

    authors: Okamura T,Korenaga D,Haraguchi M,Tsujitani S,Sugimachi K,Mori M,Enjoji M

    更新日期:1987-03-15 00:00:00

  • Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study.

    abstract:BACKGROUND:Recent evidence has identified pre-existing type 2 diabetes mellitus (T2DM) as a risk factor for the development of PAC, but relatively little is known about its effects on survival. Our aim was to determine the effect of varying durations of pre-existing T2DM on survival in patients with PAC. METHODS:We co...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27731

    authors: Hwang A,Narayan V,Yang YX

    更新日期:2013-01-15 00:00:00

  • Giant cell tumor ("osteoclastoma") of the pancreas: a tumor of epithelial origin.

    abstract::Carcinomas of the pancreas with giant cells are not rare, but those containing osteoclast-like tumor cells are quite unusual. This report documents a pancreatic neoplasm comprising both easily recognizable well-differentiated adenocarcinoma and osteoclast-like tumor. The literature on the "osteoclastoma" of the pancre...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811101)48:9<2022::aid-cncr2820

    authors: Trepeta RW,Mathur B,Lagin S,LiVolsi VA

    更新日期:1981-11-01 00:00:00

  • Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.

    abstract:BACKGROUND:Survivors of childhood leukemia/lymphoma are at increased risk for reduced bone mineral density (BMD). The authors sought to determine the frequency of reduced BMD detected by off-therapy surveillance, factors associated with reduced BMD, and the association of reduced BMD with fractures. METHODS:This cross...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32512

    authors: Bloomhardt HM,Sint K,Ross WL,Rotatori J,Ness K,Robinson C,Carpenter TO,Chow EJ,Kadan-Lottick NS

    更新日期:2020-01-01 00:00:00

  • Deferred therapy in patients with advanced disease.

    abstract::Disease that is known to have extended beyond the prostatic capsule is unlikely to be cured by radical surgical excision, although the primary tumor may be controlled by external irradiation. The development of progressive (metastatic) disease is common and may be retarded by hormonal therapy. The timing of such treat...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19930201)71:3+<1074::aid-cncr282

    authors: Smith PH

    更新日期:1993-02-01 00:00:00

  • Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanoma.

    abstract:BACKGROUND:An intensive in-patient Phase II study of continuous infusion recombinant human interleukin-2 (rhIL-2) 3 X 10(6) Roche units (9 MIU/m2)/day plus intramuscular injection of interferon-alpha-2a (rIFN-alpha-2a) 5 x 10(6) U/m2/day, four consecutive days per week, was performed to determine whether four consecuti...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Eton O,Talpaz M,Lee KH,Rothberg JM,Brell JM,Benjamin RS

    更新日期:1996-03-01 00:00:00

  • The benefit of induction chemotherapy in patients age > or = 75 years.

    abstract:BACKGROUND:Patients age > or = 75 years with acute myeloid leukemia (AML) generally are offered palliative treatments instead of induction chemotherapy. The authors conducted a retrospective study comparing the outcomes among these elderly patients with the outcomes among younger patients to assess the impact of intens...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20353

    authors: Vey N,Coso D,Bardou VJ,Stoppa AM,Braud AC,Bouabdallah R,Sainty D,Mozziconacci MJ,Lafage M,Damaj G,Blaise D,Gastaut JA,Maraninchi D

    更新日期:2004-07-15 00:00:00

  • Prognostic value of the flow cytometric DNA index in human ovarian carcinoma.

    abstract::Flow cytometric measurements were done on 51 ovarian carcinoma specimens collected from consecutive patients in a prospective study. The ploidy status was related to the course of the disease. The tumors from 26 (52%) of 50 evaluable patients had DNA aneuploidy. Patients with diploid tumors were more often considered ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880301)61:5<971::aid-cncr28206

    authors: Iversen OE

    更新日期:1988-03-01 00:00:00

  • Malignant lymphoma arising within thyroid tissue in a mature cystic teratoma.

    abstract::A 24-year-old woman was found to have a diffuse large cell lymphoma arising within thyroid tissue within a mature cystic teratoma of the ovary. To the authors' knowledge, this is the first reported case of malignant lymphoma arising within a teratoma of the ovary. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19861201)58:11<2459::aid-cncr282

    authors: Seifer DB,Weiss LM,Kempson RL

    更新日期:1986-12-01 00:00:00

  • Angio-immunoblastic lymphadenopathy terminating as Hodgkin's disease.

    abstract::The clinical course of a 33-year-old man with generalized lymphadenopathy bearing all physical, laboratory and histologic characteristics of "angio-immunoblastic lymphadenopathy with dysproteinemia" (AILD) is described. Therapy was without significant benefit and the patient died 22 months after initial diagnosis. At ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197705)39:5<2183::aid-cncr282039

    authors: Yataganas X,Papadimitriou C,Pangalis G,Loukopoulos D,Fessas P,Papacharalampous N

    更新日期:1977-05-01 00:00:00

  • Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial.

    abstract::Twenty-two patients received specific active immunotherapy (TAA vaccine once per month for 3 months), with the duration of follow-up, as of July 1984, ranging from 3 months to 36 months (median, 21 months). Of these, seven had Dukes B2, seven had Dukes C, and eight had Dukes D lesions. All received surgical resection,...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850801)56:3<480::aid-cncr28205

    authors: Hollinshead A,Elias EG,Arlen M,Buda B,Mosley M,Scherrer J

    更新日期:1985-08-01 00:00:00

  • High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.

    abstract:BACKGROUND:High mobility group AT-hook 1 (HMGA1) proteins are architectural transcription factors that are overexpressed by pancreatic adenocarcinomas. The authors hypothesized that tumor HMGA1 status represents a novel prognostic marker in pancreatic adenocarcinoma. They also tested the hypothesis that HMGA1 promotes ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23560

    authors: Liau SS,Rocha F,Matros E,Redston M,Whang E

    更新日期:2008-07-15 00:00:00

  • Cancer prevention and detection. An overview of variables influencing adoption and practice.

    abstract::This paper presents an overview of factors, attitudes, and beliefs that may influence the adoption of cancer prevention and detection strategies by health-care providers and the public. Health-care practitioners require education about prevention and detection approaches to health care and the social variations in the...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19880601)61:11+<2391::aid-cncr28

    authors: Fink DJ,Sheehan HE

    更新日期:1988-06-01 00:00:00

  • Primary seminoma of the mediastinum. Cancer Control Agency of British Columbia experience.

    abstract::Six patients with primary seminoma of the mediastinum were treated at the Cancer Control Agency of British Columbia during the period from 1970 to 1982. Primary treatment used was external beam radiotherapy. Only one patient received both radiotherapy and chemotherapy. Tumor dose ranged from 3000 cGy in 16 daily fract...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850115)55:2<450::aid-cncr28205

    authors: Lee YM,Jackson SM

    更新日期:1985-01-15 00:00:00